Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
This is a Class II voluntary recall of a subpotent vasopressin injectable product compounded by IntegraDose Compounding Services LLC, not a regulatory change affecting peptide research supply. Vasopressin is a peptide hormone, but this recall concerns a specific compounded drug product's potency failure rather than industry-wide policy. The impact on peptide research vendors is minimal and informational only.
Compounding pharmacies and distributors handling these specific vasopressin lots should quarantine and return affected product. Peptide research vendors are not directly affected but should note FDA scrutiny on compounded peptide-hormone potency.
May 18, 2026
Alert created: Jun 30, 2026, 3:48 PM